Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advances in adjuvant hormonal therapy for postmenopausal women.

× No keyword cloud information.

20 in total

Review 1. Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies.

Authors: Weimin Fan; Jinjia Chang; Peifeng Fu
Journal: Future Med Chem Date: 2015-08-26 Impact factor: 3.808

Review 2. Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer.

Authors: Xiaoyong Fu; C Kent Osborne; Rachel Schiff
Journal: Breast Date: 2013-09-05 Impact factor: 4.380

3. ESR1 and endocrine therapy resistance: more than just mutations.

Authors: S Piscuoglio; C K Y Ng; B Weigelt; S Chandarlapaty; J S Reis-Filho
Journal: Ann Oncol Date: 2018-04-01 Impact factor: 32.976

4. Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.

Authors: Abdelrahman S Mayhoub; Laura Marler; Tamara P Kondratyuk; Eun-Jung Park; John M Pezzuto; Mark Cushman
Journal: Bioorg Med Chem Date: 2011-09-25 Impact factor: 3.641

5. Immunohistochemical analysis of estrogen receptor in breast cancer with ESR1 mutations detected by hybrid capture-based next-generation sequencing.

Authors: Dara S Ross; Ahmet Zehir; Edi Brogi; Fumiko Konno; Melissa Krystel-Whittemore; Marcia Edelweiss; Michael F Berger; Weiyi Toy; Sarat Chandarlapaty; Pedram Razavi; José Baselga; Hannah Y Wen
Journal: Mod Pathol Date: 2018-08-29 Impact factor: 7.842

6. Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A).

Authors: L P Hemachandra; P Madhubhani; R Chandrasena; P Esala; Shao-Nong Chen; Matthew Main; David C Lankin; Robert A Scism; Birgit M Dietz; Guido F Pauli; Gregory R J Thatcher; Judy L Bolton
Journal: Cancer Prev Res (Phila) Date: 2011-10-13

7. Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrant.

Authors: Eric A Ariazi; Joan S Lewis-Wambi; Shaun D Gill; Jennifer R Pyle; Jennifer L Ariazi; Helen R Kim; Catherine G N Sharma; Fernando Cordera; Heather A Shupp; Tianyu Li; V Craig Jordan
Journal: J Steroid Biochem Mol Biol Date: 2006-11-07 Impact factor: 4.292

Review 8. Mechanisms of hormonal therapy resistance in breast cancer.

Authors: Shin-ichi Hayashi; Mariko Kimura
Journal: Int J Clin Oncol Date: 2015-02-05 Impact factor: 3.402

Review 9. Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance.

Authors: Rocío García-Becerra; Nancy Santos; Lorenza Díaz; Javier Camacho
Journal: Int J Mol Sci Date: 2012-12-20 Impact factor: 5.923

10. Adjuvant Hormonal Therapy in Postmenopausal Women with Breast Cancer: Physician's Choices.

Authors: Asim Jamal Shaikh; Shiyam Kumar; Sajjad Raza; Maria Mehboob; Osama Ishtiaq
Journal: Int J Breast Cancer Date: 2012-12-09